Convalescent plasma transfusion for immunocompromised viremic patients with COVID‐19: A retrospective multicenter study

• Published in: Journal of medical virology Vol. 96; no. 4; pp. e29603 - n/a
• Main Authors: Destremau, Marjolaine, Chaussade, Hélène, Hemar, Victor, Beguet, Mathilde, Bellecave, Pantxika, Blanchard, Elodie, Barret, Amaury, Laboure, Gaelle, Vasco‐Moynet, Claire, Lacassin, Flore, Morisse, Eloïse, Aguilar, Claire, Lafarge, Xavier, Lafon, Marie‐Edith, Bonnet, Fabrice, Issa, Nahéma, Camou, Fabrice
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.04.2024; Wiley-Blackwell
• Subjects: Autoimmune diseases; Blood Component Transfusion; CD20 antigen; Chemotherapy; Cohort Studies; combination therapy; Coronaviruses; COVID-19; COVID-19 - therapy; COVID-19 Serotherapy; disease control; Hematologic Neoplasms - complications; Hematologic Neoplasms - therapy; Humans; Immunocompromised Host; Immunocompromised hosts; infection; Life Sciences; Malignancy; Mortality; Plasma; Santé publique et épidémiologie; SARS coronavirus; Serology; Transfusion; Transplants; Viral diseases; Viremia; virus classification; disease control; combination therapy; infection; virus classification; SARS coronavirus; Plasma; Hematologic Neoplasms; Viremia; Humans; disease control infection SARS coronavirus virus classification; COVID-19; Blood Component Transfusion; COVID-19 Serotherapy; Immunocompromised Host; Cohort Studies

This study aims to assess the safety, virological, and clinical outcomes of convalescent plasma transfusion (CPT) in immunocompromised patients hospitalized for coronavirus disease 2019 (COVID‐19). We conducted a retrospective multicenter cohort study that included all immunosuppressed patients with...